UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) May 3, 2007
Pharmion Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-50447
|
|
84-1521333 |
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.) |
|
|
|
2525 28th Street, Boulder, Colorado
|
|
80301 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
Registrants telephone number, including area code 720-564-9100
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|
|
|
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
|
|
Item 7.01 |
|
Regulation FD Disclosure |
On May 2, 2007, Pharmion Corporation (the Company) issued
a press release announcing a proposed public offering of its
common stock through a registration statement which has been
filed with the Securities and Exchange Commission and has
become effective. A copy of the press release is attached
as Exhibit 99.1.
This information is furnished pursuant to Item 7.01 of Form
8-K and shall not be deemed to be filed for the purposes
of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to liability under that
section, nor shall it be deemed incorporated by reference
into any filing under the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934, as amended,
except as shall be expressly set forth by specific reference
in such filing. By filing this report on Form 8-K and
furnishing this information, the Company makes no admission
as to the materiality of any information in this report that
is required to be disclosed solely by reason of Regulation
FD.
|
|
|
Item 9.01 |
|
Financial Statements and Exhibits. |
This information shall not be deemed
to be filed for the purposes of
Section 18 of the Securities Exchange
Act of 1934, as amended, or otherwise
subject to liability under that
section, nor shall it be deemed
incorporated by reference into any
filing under the Securities Act of
1933, as amended, or the Securities
Exchange Act of 1934, as amended,
except as shall be expressly set
forth by specific reference in such
filing.
(d) Exhibits
|
|
|
Exhibit |
|
|
Number |
|
Description |
|
99.1
|
|
Press Release, dated May 2, 2007. |
-2-